personalized medicine
Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients
The first interventional trial to use ctDNA to recruit eligible patients for this treatment showed 30 percent observable responses and more than 60 percent disease control.
Tool Detects Pediatric Bone Tumors From Liquid Biopsies Based on Epigenetic Profiles
Epigenetic signatures of Ewing sarcoma affect cell-free DNA fragmentation patterns and can be used to detect cancer.
The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant.
Sema4, AdventHealth Collaborate on Analysis-Driven Personalized Health Program
The partners will structure and curate genomic and longitudinal clinical data for AI-based analysis using Sema4's Centrellis cloud-based health intelligence platform.
Caris Life Sciences, National Cancer Center Japan Partner for New Arm of SCRUM-Japan Study
Patients in the multicenter study will gain access to Caris' comprehensive tumor profiling platform as well as algorithms for chemotherapy prediction and tumor typing.